PTC Therapeutics
PTCT
PTCT
211 hedge funds and large institutions have $3.94B invested in PTC Therapeutics in 2022 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more funds holding
Funds holding: 179 → 211 (+32)
5.61% more ownership
Funds ownership: 103.88% → 109.49% (+5.6%)
21% less call options, than puts
Call options by funds: $8.95M | Put options by funds: $11.4M
Holders
211
Holding in Top 10
8
Calls
$8.95M
Puts
$11.4M
Top Buyers
| 1 | +$101M | |
| 2 | +$28.9M | |
| 3 | +$26.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$23M |
| 5 |
Millennium Management
New York
|
+$22.2M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$22.2M | |
| 3 | -$19.9M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$13.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.72M |